Treatment Response to Hydroxychloroquine, Lopinavir/Ritonavir, and Antibiotics for Moderate COVID 19: A First Report on the Pharmacological Outcomes from South Korea
Kim et al., medRxiv, doi:10.1101/2020.05.13.20094193
https://c19hcq.org/kim.html